BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27939336)

  • 1. Adjuvant Chemotherapy is Indicated in Patients with Lower Grade Glioma.
    Brown N; Carter T; Mulholland P
    Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):141-142. PubMed ID: 27939336
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for low-grade glioma: when, for whom, which regimen?
    van den Bent MJ
    Curr Opin Neurol; 2015 Dec; 28(6):633-938. PubMed ID: 26397230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.
    Youland RS; Kreofsky CR; Schomas DA; Brown PD; Buckner JC; Laack NN
    J Neurooncol; 2017 Dec; 135(3):535-543. PubMed ID: 28836106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
    Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
    Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy.
    Valeriani M; Ferretti A; Franzese P; Tombolini V
    Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
    Jang BS; Kim IA
    Radiother Oncol; 2018 Aug; 128(2):245-253. PubMed ID: 29784449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy in the treatment of high grade gliomas.
    Lonardi S; Tosoni A; Brandes AA
    Cancer Treat Rev; 2005 Apr; 31(2):79-89. PubMed ID: 15847978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
    Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
    J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.
    Antoni D; Jastaniah Z; Haoming QC; Gaultier C; Ahle G; Couchot J; Atlani D; Schott R; Clavier JB; Srour R; Chaussemy D; Noël G
    Cancer Radiother; 2016 Jun; 20(4):282-91. PubMed ID: 27318555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review.
    Hafazalla K; Sahgal A; Jaja B; Perry JR; Das S
    Oncotarget; 2018 Sep; 9(72):33623-33633. PubMed ID: 30263090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
    Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
    J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
    Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
    Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol.
    Wolff JE; Driever PH; Erdlenbruch B; Kortmann RD; Rutkowski S; Pietsch T; Parker C; Metz MW; Gnekow A; Kramm CM
    Cancer; 2010 Feb; 116(3):705-12. PubMed ID: 19957326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Grade Glioma with Foci of Early Transformation Does Not Necessarily Require Adjuvant Therapy After Radical Surgical Resection.
    Al-Tamimi YZ; Palin MS; Patankar T; MacMullen-Price J; O'Hara DJ; Loughrey C; Chakrabarty A; Ismail A; Roberts P; Duffau H; Goodden JR; Chumas PD
    World Neurosurg; 2018 Feb; 110():e346-e354. PubMed ID: 29129767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in the use of chemotherapy in brain tumours.
    van den Bent MJ; Hegi ME; Stupp R
    Eur J Cancer; 2006 Mar; 42(5):582-8. PubMed ID: 16427778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma.
    Haque W; Verma V; Butler EB; Teh BS
    J Neurooncol; 2017 Jun; 133(2):369-375. PubMed ID: 28432588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery.
    Roux A; Caire F; Guyotat J; Menei P; Metellus P; Pallud J;
    Neurochirurgie; 2017 Dec; 63(6):433-443. PubMed ID: 29122306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide.
    Monje ML; Ramakrishna NR; Young G; Drappatz J; Doherty LM; Wen PY; Kesari S
    J Neurooncol; 2007 Sep; 84(2):179-83. PubMed ID: 17332945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary spinal glioma in children: Results from a referral pediatric institution in Shanghai.
    Khalil J; Chuanying Z; Qing Z; Belkacémi Y; Mawei J
    Cancer Radiother; 2017 Jun; 21(4):261-266. PubMed ID: 28522280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of temozolomide treatment in patients with high-grade glioma.
    Oshiro S; Tsugu H; Komatsu F; Ohmura T; Ohta M; Sakamoto S; Fukushima T; Inoue T
    Anticancer Res; 2009 Mar; 29(3):911-7. PubMed ID: 19414327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.